These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28550310)

  • 21. SRSF9 selectively represses ADAR2-mediated editing of brain-specific sites in primates.
    Shanmugam R; Zhang F; Srinivasan H; Charles Richard JL; Liu KI; Zhang X; Woo CWA; Chua ZHM; Buschdorf JP; Meaney MJ; Tan MH
    Nucleic Acids Res; 2018 Aug; 46(14):7379-7395. PubMed ID: 29992293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases.
    Yang W; Chendrimada TP; Wang Q; Higuchi M; Seeburg PH; Shiekhattar R; Nishikura K
    Nat Struct Mol Biol; 2006 Jan; 13(1):13-21. PubMed ID: 16369484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis.
    Galeano F; Rossetti C; Tomaselli S; Cifaldi L; Lezzerini M; Pezzullo M; Boldrini R; Massimi L; Di Rocco CM; Locatelli F; Gallo A
    Oncogene; 2013 Feb; 32(8):998-1009. PubMed ID: 22525274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ADAR2 affects mRNA coding sequence edits with only modest effects on gene expression or splicing in vivo.
    Dillman AA; Cookson MR; Galter D
    RNA Biol; 2016; 13(1):15-24. PubMed ID: 26669816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal expression of an ADAR2 alternative splicing variant in gliomas downregulates adenosine-to-inosine RNA editing.
    Wei J; Li Z; Du C; Qi B; Zhao X; Wang L; Bi L; Wang G; Zhang X; Su X; Pan Y; Tian Y
    Acta Neurochir (Wien); 2014 Jun; 156(6):1135-42. PubMed ID: 24509948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprogramming of microRNAs by adenosine-to-inosine editing and the selective elimination of edited microRNA precursors in mouse oocytes and preimplantation embryos.
    García-López J; Hourcade Jde D; Del Mazo J
    Nucleic Acids Res; 2013 May; 41(10):5483-93. PubMed ID: 23571754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine deaminases that act on RNA induce reproducible changes in abundance and sequence of embryonic miRNAs.
    Vesely C; Tauber S; Sedlazeck FJ; von Haeseler A; Jantsch MF
    Genome Res; 2012 Aug; 22(8):1468-76. PubMed ID: 22310477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex.
    Kawahara Y; Zinshteyn B; Chendrimada TP; Shiekhattar R; Nishikura K
    EMBO Rep; 2007 Aug; 8(8):763-9. PubMed ID: 17599088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using mouse models to unlock the secrets of non-synonymous RNA editing.
    Jinnah H; Ulbricht RJ
    Methods; 2019 Mar; 156():40-45. PubMed ID: 30827465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic regulation of RNA editing in human brain development and disease.
    Hwang T; Park CK; Leung AK; Gao Y; Hyde TM; Kleinman JE; Rajpurohit A; Tao R; Shin JH; Weinberger DR
    Nat Neurosci; 2016 Aug; 19(8):1093-9. PubMed ID: 27348216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deciphering the principles of the RNA editing code via large-scale systematic probing.
    Uzonyi A; Nir R; Shliefer O; Stern-Ginossar N; Antebi Y; Stelzer Y; Levanon EY; Schwartz S
    Mol Cell; 2021 Jun; 81(11):2374-2387.e3. PubMed ID: 33905683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A-to-I editing of coding and non-coding RNAs by ADARs.
    Nishikura K
    Nat Rev Mol Cell Biol; 2016 Feb; 17(2):83-96. PubMed ID: 26648264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel tissue-specific alternatively spliced form of the A-to-I RNA editing enzyme ADAR2.
    Agranat L; Sperling J; Sperling R
    RNA Biol; 2010; 7(2):253-62. PubMed ID: 20215858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
    Nakano M; Fukami T; Gotoh S; Nakajima M
    J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas.
    Tomaselli S; Galeano F; Massimi L; Di Rocco C; Lauriola L; Mastronuzzi A; Locatelli F; Gallo A
    BMC Cancer; 2013 May; 13():255. PubMed ID: 23697632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
    Wang G; Wang JJ; Tang HM; To SS
    Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large-scale prediction of ADAR-mediated effective human A-to-I RNA editing.
    Yao L; Wang H; Song Y; Dai Z; Yu H; Yin M; Wang D; Yang X; Wang J; Wang T; Cao N; Zhu J; Shen X; Song G; Zhao Y
    Brief Bioinform; 2019 Jan; 20(1):102-109. PubMed ID: 28968662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolutionarily conserved A-to-I editing increases protein stability of the alternative splicing factor Nova1.
    Irimia M; Denuc A; Ferran JL; Pernaute B; Puelles L; Roy SW; Garcia-Fernàndez J; Marfany G
    RNA Biol; 2012 Jan; 9(1):12-21. PubMed ID: 22258141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA editing of human microRNAs.
    Blow MJ; Grocock RJ; van Dongen S; Enright AJ; Dicks E; Futreal PA; Wooster R; Stratton MR
    Genome Biol; 2006; 7(4):R27. PubMed ID: 16594986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perturbation of biogenesis and targeting of Epstein-Barr virus-encoded miR-BART3 microRNA by adenosine-to-inosine editing.
    Lei T; Yuen KS; Tsao SW; Chen H; Kok KH; Jin DY
    J Gen Virol; 2013 Dec; 94(Pt 12):2739-2744. PubMed ID: 24045110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.